Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q3 EPS of ($0.30), $0.58 better than the analyst estimate of ($0.88).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.